Organization | First Wave Bio, Inc.

First Wave Bio, Inc. Report issue

For profit Phase 2

Founded: Ann Arbor MI United States (2015)

Status: No NME R&D (2015)

Organization Overview

First Clinical Trial

2018

NCT03521232

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2023

Timeline

NOW

Historical Acquisition Tree

Alternative names

First Wave Bio, Inc. | First Wave BioPharma, Inc.

Active Ingredients

Key: First Wave Bio, Inc. (0) Acquired (3)

Indications

Proctitis (Phase 2)

Ulcer (Phase 2)